Treatment of Cat Scratch Fever
Azithromycin is the recommended first-line treatment for cat scratch disease, with a dosing protocol of 500 mg on day 1 followed by 250 mg for 4 additional days for patients >45 kg, or 10 mg/kg on day 1 and 5 mg/kg for 4 more days for patients <45 kg. 1
Clinical Presentation and Diagnosis
Cat scratch disease (CSD) is caused by Bartonella henselae, a fastidious gram-negative bacillus transmitted through cat scratches or bites. The clinical presentation typically includes:
- A papule or pustule developing 3-30 days after a scratch or bite 1
- Regional lymphadenopathy occurring approximately 3 weeks after inoculation 1
- Lymphadenopathy generally resolving within 1-6 months, with suppuration in about 10% of cases 1
- Extranodal disease (affecting CNS, liver, spleen, bone, lung) developing in ≤2% of cases 1
Diagnosis is typically based on:
- History of cat exposure 2
- Serologic testing with high titers (>1:256) of IgG antibody to B. henselae 2
- PCR or Warthin-Starry silver stain of infected lymph node tissue in difficult cases 1
Treatment Algorithm
Immunocompetent Patients with Typical CSD
First-line treatment: Azithromycin
Alternative treatments (if azithromycin is contraindicated):
Immunocompromised Patients with Bacillary Angiomatosis
For immunocompromised patients (especially those with HIV/AIDS) who develop bacillary angiomatosis:
- First-line treatment: Erythromycin 500 mg four times daily or doxycycline 100 mg twice daily for 2 weeks to 2 months 1
- Alternative treatment: Clarithromycin or azithromycin 1
- Duration: Therapy should be administered for >3 months 1
- For CNS involvement: Doxycycline with or without rifampin 1
Prevention of Recurrence
- Long-term suppression with erythromycin or doxycycline should be considered for patients with relapse or reinfection 1
- For pregnant women requiring long-term suppression, erythromycin should be used (tetracyclines are contraindicated during pregnancy) 1
Evidence Quality and Treatment Efficacy
The recommendation for azithromycin is based on a placebo-controlled study showing more rapid reduction in lymph node size (80% regression at 30 days) in patients receiving azithromycin compared to placebo (P = .02) 1. This represents the strongest evidence available for treatment efficacy.
Most cases of cat scratch disease in immunocompetent hosts are self-limited and may not require antibiotic therapy 4, 2. However, treatment is recommended for:
- Severe or persistent cases 5
- Patients with systemic symptoms 2
- Immunocompromised patients 1
- Cases with extranodal or disseminated disease 1
Prevention Measures
For prevention of Bartonella infection, especially in immunocompromised individuals:
- Consider risks of cat ownership, particularly for severely immunosuppressed persons 1
- If acquiring a cat, choose one >1 year old in good health 1
- Avoid rough play with cats and situations where scratches are likely 1
- Promptly wash any cat-associated wounds 1
- Implement comprehensive flea control for cats 1
- Do not allow cats to lick open wounds 1